Oscar Health ($OSCR) Insider Trading & Smart Money Activity
Oscar Health, Inc. ($OSCR) has 5 insider trades and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 3 insiders sold ($65.90M), net -$65.90M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 3
- Net insider $ (12 mo)
- -$65.90M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 1
OSCR insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 3 · $65.10M | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 1 · $806K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All OSCR insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Wittman Vanessa AmesDirector | Sell (Open-market sale) 10b5-1 | 25K sh | $806K | — | ||||||
| Insider | Mark BertoliniChief Executive Officer | Sell (Open-market sale) 10b5-1 | 591.17K sh | $17.31M | — | ||||||
| Insider | Mark BertoliniChief Executive Officer | Sell (Open-market sale) 10b5-1 | 615.14K sh | $17.60M | — | ||||||
| Insider | Mario Schlosser | Sell (Open-market sale) 10b5-1 | 1.03M sh | $30.18M | — | ||||||
| Insider | Mario Schlosser | Buy (Conversion) | 1.03M sh | — | |||||||
| Analyst | Barclays | Raises to buy | PT $35 | — |
1W / 1M / 6M = how OSCR moved from the trade or filing date.
Insider trading in OSCR: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Wittman Vanessa Ames | Director | 1 | -$806K | Sep 18, 2026 | |
| Mark Bertolini | Chief Executive Officer | 2 | -$34.91M | Jun 26, 2026 | |
| Mario Schlosser | 2 | -$30.18M | Jun 23, 2026 |
Analyst ratings on OSCR
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Barclays | Raises | buy | $35 | — |
Frequently asked questions
Are OSCR insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 3 insiders made 4 open-market sales worth $65.90M, a net -$65.90M.
What is the latest insider trade in OSCR?
Wittman Vanessa Ames, Director filed a sell (open-market sale) of 25K sh worth $806K on Sep 18, 2026.
Other healthcare plans stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.